Roche Receives CE Mark for Alzheimer’s Disease Blood Test
Roche received the CE mark for its Elecsys pTau217 blood test, an assay designed to detect Alzheimer’s disease…
Roche’s Elecsys pTau217 blood test secures CE mark for Alzheimer’s
Roche has secured CE mark for the Elecsys pTau217 blood test, developed alongside Eli Lilly, for detecting Alzheimer’s…
Roche’s Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer’s-related amyloid pathology
Rules out Alzheimer’s pathology in early stages to enhance diagnostic pathway efficiency Provides new opportunity to broaden access…
Roche’s Elecsys pTau181 test gains CE Mark to rule out Alzheimer’s
Roche’s Elecsys pTau181 test has secured CE Mark approval, marking a development in ruling out Alzheimer’s disease. The…